Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2009
11/03/2009US7612094 Tri-substituted heteroaryls and methods of making and using the same
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
11/03/2009US7612087 Heterocyclic compounds as inhibitors of beta-lactamases
11/03/2009US7612070 Indole derivative having heterocycle and mono- or diazaindole derivative
11/03/2009US7612067 Imidazopyridazine compounds
11/03/2009US7612036 Such as methyl (2S,5S,8R/S)-8-acetamido-2-allyl-9-[6-allyl-9-tert-butoxycarbonyl-9H-carbazol-3-yl]-3,6-diaza-5-{3-[(2,2,5,7,8-pentamethylchroman-6-sulfonyl)-guanidino]propyl}-4,7-dioxononanoate; for treatment of bacterial infections, such as those caused by vancomycin resistant microorganisms
11/03/2009US7611888 Rotaxane compound, rotaxane-bonded solid substrate, and biochip using the same
11/03/2009CA2443724C Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
11/03/2009CA2410037C 3-phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors
11/03/2009CA2368834C Bicyclic heteroaromatic compounds useful as lh agonists
10/2009
10/30/2009CA2638573A1 Substituted 7-azabicyclo[2.2.1]heptyl derivatives useful for making pharmaceutical compositions
10/29/2009WO2009132136A1 Carboxamide compounds for the treatment of metabolic disorders
10/29/2009WO2009132135A1 1' -substituted carba-nucleoside analogs for antiviral treatment
10/29/2009WO2009132123A1 Carba-nucleoside analogs for antiviral treatment
10/29/2009WO2009131975A1 Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use
10/29/2009WO2009131974A1 Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use
10/29/2009WO2009131940A1 Limk2 inhibitors, compositions comprising them, and methods of their use
10/29/2009WO2009131246A1 Sordarin derivatives for preventing or treating infectious diseases caused by pathogenic microorganisms
10/29/2009WO2009131096A1 Compound having npy y5 receptor antagonist activity
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009WO2009130873A1 Hydroalkane sulfonate and use thereof
10/29/2009WO2009130560A1 Fused pyrimidineone compounds as trpv3 modulators
10/29/2009WO2009130317A1 1- (7-(hexahydropyrrolo [3, 4-c] pyrrol-2 (1h) -yl) quin0lin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (gsk-3)
10/29/2009WO2009130232A1 Pyrazolo [1, 5 -a] pyrazine derivatives as antagonists of v1b receptors
10/29/2009WO2009130231A1 Pyrrolo [1, 2-a] pyrazine derivatives as vasopressin vib receptor antagonists
10/29/2009WO2009130016A1 Dihydropteridinones as plk inhibitors
10/29/2009WO2009109782A3 Polycyclic organic compounds, retardation layer and compensation panel based thereon
10/29/2009WO2009109781A3 Polycyclic organic compounds, polarizing elements and method of production thereof
10/29/2009WO2009093208A3 Substituted 2-amino-3-sulfonyl-pyrazolo[1,5-a] pyrimidines/antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof
10/29/2009WO2009093206A3 3-sulfonyl-pyrazolo[1,5-a] pyrimidines / antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof
10/29/2009WO2009084024A3 A process for the preparation of r-sit agliptin and its pharmaceutically acceptable salts thereof
10/29/2009WO2009083530A3 Fluoride processing method
10/29/2009US20090270467 5-[(1S,3S,4R)-3-Amino-4-(2,4,5-trifluorophenyl)cyclohexyl]-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-amine, used for treating insulin resistance, hyperglycemia and non-insulin dependent diabetes in mammals
10/29/2009US20090270446 Diamine derivatives
10/29/2009US20090270431 Cyclopentenol Nucleoside Compounds Intermediates for their Synthesis and Methods of Treating Viral Infections
10/29/2009US20090270426 P13 Kinase Antagonists
10/29/2009US20090270425 3-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
10/29/2009US20090270402 Novel triazolopyridazines
10/29/2009US20090270388 Fused azole-pyrimidine derivatives
10/29/2009US20090270379 Quinolone derivatives useful as antibacterial agents
10/29/2009US20090270370 Fused heterocyclic compounds
10/29/2009US20090270369 Bicycloamine derivatives
10/29/2009DE102008021699A1 New pyrrolopyrimidine compounds are epidermal growth factor receptor tyrosine kinase inhibitors useful for preventing or treating proliferative or inflammatory disease, where the disease is e.g. cancer, asthma, allergy and psoriasis
10/29/2009CA2723222A1 Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use
10/29/2009CA2722177A1 1'-substituted carba-nucleoside analogs for antiviral treatment
10/29/2009CA2722139A1 Carboxamide compounds for the treatment of metabolic disorders
10/29/2009CA2722084A1 Carba-nucleoside analogs for antiviral treatment
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2721919A1 Limk2 inhibitors, compositions comprising them, and methods of their use
10/29/2009CA2721750A1 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
10/29/2009CA2721738A1 Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use
10/29/2009CA2721576A1 Compound having npy y5 receptor antagonist activity
10/29/2009CA2720659A1 1-(7-(hexahydropyrrolo[3,4-c]pyrrol-2(1h)-yl)quinolin-4-yl)-3-(pyrazin-2-yl)urea derivatives and related compounds as glycogen synthase kinase 3 (gsk-3)
10/29/2009CA2720357A1 Fused pyrimidineone compounds as trpv3 modulators
10/28/2009EP2112153A1 Method of reducing alpha, beta- unsaturated ketones in opioid compositions
10/28/2009EP2112152A1 Dihydropteridinones as Plk Inhibitors
10/28/2009EP2111405A1 Intermediates useful in preparing certain pyrrolotriazine compounds and a process for making the intermediates
10/28/2009EP2111404A1 Method for production of aryl-substituted annelated pyrimidines
10/28/2009EP2111403A1 Triazabenzo[e]azulene derivatives for the treatment of tumors
10/28/2009EP2111402A2 Aminopyrazole kinase inhibitors
10/28/2009EP1745052B9 Hiv integrase inhibitors: cyclic pyrimidinone compounds
10/28/2009EP1633717B1 P2x7 receptor antagonists and their use
10/28/2009CN101568544A Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and use therewith
10/28/2009CN101568543A Macrocyclic peptides as hepatitis c virus inhibitors
10/28/2009CN101568542A 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives
10/28/2009CN101568540A Tricyclic heteroaryl compounds useful as inhibitors of janus kinase
10/28/2009CN101568532A Cyclic derivatives as modulators of chemokine receptor activity
10/28/2009CN101568530A Indol-4-yl-pyrimidinyl-2-yl-amine derivatives and use thereof as cyclin dependant kinase inhibitors
10/28/2009CN101568527A 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
10/28/2009CN101568336A Macrocyclic peptides as hepatitis C virus inhibitors
10/28/2009CN101567425A Organic electroluminescence device, novel platinum complex compound and novel compound capable of being a ligand thereof
10/28/2009CN101565556A Preparation method for solvent orange 60
10/28/2009CN101565421A 1-3 substituted aryloxide dendritic phthalocyanine complexes as well as preparation method and use thereof
10/28/2009CN101565420A LIMK2 inhibitors, compositions comprising them, and methods of their use
10/28/2009CN101565404A Heterocyclic compounds
10/28/2009CN100554269C Method for preparing triazolepyrimidine compounds
10/28/2009CN100554268C Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
10/27/2009US7608710 Including polyether substituents including pendant alkoxy fluoroalkyl groups; for wetting, leveling and flow agents in solvent-borne coating systems
10/27/2009US7608687 Releasable linkage and compositions containing same
10/27/2009US7608624 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
10/27/2009US7608622 1 -Phenylerhyl)-6-(3,4,5-trimethoxyphenyl)- 1 ,3-dihydroimidazo[4,5-b]pyrazin-2-one;
10/27/2009US7608603 preferential enzyme inhibitors comprising fused pyrazolo pyrimidine derivatives used for treating arthritis, Crohns disease, irritable bowel syndrome, adult respiratory distress syndrome, or chronic obstructive pulmonary disease
10/27/2009US7608590 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV)
10/27/2009CA2536886C Crystal of 1-methyl carbapenem compound
10/27/2009CA2493359C Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-.alpha.]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
10/27/2009CA2465534C Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
10/27/2009CA2454664C Cancer treatment with go6976 and its related compounds
10/27/2009CA2446435C 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives
10/27/2009CA2415966C Tetrahydro-heterocycloazepinyl pyrimidine derivatives
10/27/2009CA2381885C Isomeric fused pyrrolocarbazoles and isoindolones
10/27/2009CA2341434C Pyrrolobenzodiazepine compounds
10/27/2009CA2318976C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
10/22/2009WO2009128520A1 Heterocyclic compound having inhibitory activity on p13k
10/22/2009WO2009128481A1 Nitrogenated 5-membered heterocyclic compound
10/22/2009WO2009127815A1 Aminoalyl-imidazotetrazines for treatment of cancer
10/22/2009WO2009100120A3 Pyridinyl-substituted piperazinyl oxoethyl tetrahydropyrazolopyridines
10/22/2009WO2009077956A3 HETEROCYCLIC INHIBITORS OF AN Hh-SIGNAL CASCADE, MEDICINAL COMPOSITIONS BASED THEREON AND METHODS FOR TREATING DISEASES CAUSED BY THE ABERRANT ACTIVITY OF AN Hh-SIGNAL SYSTEM
10/22/2009US20090264493 Process for Producing Aqueous Solution of Doripenem
10/22/2009US20090264467 Agents and crystals for improving excretory potency of urinary bladder
10/22/2009US20090264450 Limk2 inhibitors, compositions comprising them, and methods of their use
1 ... 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 ... 573